Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
11.09
-0.14 (-1.25%)
Nov 21, 2024, 1:24 PM EST - Market open
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $758.75 million as of November 21, 2024. Its market cap has increased by 18.63% in one year.
Market Cap
758.75M
Enterprise Value
412.39M
1-Year Change
18.63%
Ranking
Category
Stock Price
$11.09
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $758.75M, an increase of 62.29%. That is a compound annual growth rate of 7.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 771.85M |
| Pacira BioSciences | 768.32M |
| Evolus | 759.22M |
| Pliant Therapeutics | 749.72M |
| CARGO Therapeutics | 738.75M |
| Bioventus | 735.39M |
| Prothena Corporation | 726.96M |
| Orthofix Medical | 698.94M |